Evaluation of various antibiotics used in the treatment of cellulitis at a tertiary care hospital
DOI:
https://doi.org/10.18203/2320-6012.ijrms20195921Keywords:
Antibiotics, Cellulitis, Infectious disease society of America, Left limb cellulitis, Length of stay, Rational use of antibioticsAbstract
Background: Cellulitis is an inflammation of the skin and subcutaneous tissues, usually resulting from microbial invasion. It may occur as a result of tissue injury. The mainstay of treatment includes antibiotic therapy based on the susceptibility and severity of infection. The aim of the study is to evaluate various antibiotics used in the treatment of cellulitis at a tertiary care hospital.
Methods: Participants were patients referred by Dermatologists, General surgeons with acute and complicated cellulitis. Demographic data, Clinical and biochemical data were analyzed at admission. Then the time taken for improvement of symptoms and length of stay were analyzed.
Results: A total of 58 patients were included in the study of which 38(65.5%) patients were male and 20(34.4%) patients were female. Patients having comorbid conditions were found to be having higher length of stay (mean±SD-13.7±3.6 days), severity of infection and antibiotic therapy. Patients with diabetes(mean±SD-16.8±4days) have higher length of stay and slow wound healing. Patients with left leg cellulitis 32(55%) were higher than the right leg cellulitis 17(29%). The reason behind this remains undetermined, which highlights scope for future research in this region.
Conclusions: Management of patients was done with mono or dual/combination antibiotic therapy or surgical treatment was done based on clinical response. According to our study patients with co-morbidities especially Diabetes have slow prognosis of cellulitis as they required longer length of stay in a hospital and prolonged treatment. Rational clinical decision on the use of various antibiotics shall be implemented based on evidence-based methods such as iv-to-po shift, regular evaluation of clinical response and stepping down to a narrow-spectrum to reduce the length of stay which can improve the paradigm and the positive clinical response for the management of cellulitis.
Metrics
References
Cranendonk DR, Lavrijsen APM, Prins JM, Wiersinga WJ. Cellulitis: current insights into pathophysiology and clinical management. Neth J Med. 2017;75(9):366-78.
Tianyi FL, Mbanga CM, Danwang C, Agbor VN. Risk factors and complications of lower limb cellulitis in Africa: a systematic review. BMJ Open. 2018 Jul 1;8(7):e021175.
Ramakrishnan K, Salinas RC, Agudelo Higuita NI. Skin and Soft Tissue Infections. Am Family Phys. 2015 Sep 15;92(6).
Cannon J, Rajakaruna G, Dyer J, Carapetis J, Manning L. Severe lower limb cellulitis: defining the epidemiology and risk factors for primary episodes in a population-based case-control study. Clin Microbiol Inf. 2018 Oct 1;24(10):1089-94.
Leong HN, Kurup A, Tan MY, Kwa AL, Liau KH, Wilcox MH. Management of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics. Inf Drug Resist. 2018;11:1959.
Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Inf Dis. 2014 Jul 15;59(2):e10-52.
Kwak YG, Choi SH, Kim T, Park SY, Seo SH, Kim MB, et al. Clinical guidelines for the antibiotic treatment for community-acquired skin and soft tissue infection. Inf Chemo. 2017 Dec 1;49(4):301-25.
Alanis AJ. Resistance to antibiotics: are we in the post-antibiotic era?. Archiv Med Res. 2005 Nov 1;36(6):697-705.
Machowska A, Stålsby Lundborg C. Drivers of irrational use of antibiotics in Europe. Int J Environm Res Pub Health. 2019 Jan;16(1):27.
Björnsdóttir S, Gottfredsson M, Thórisdóttir AS, Gunnarsson GB, Rikardsdottir H, Kristjánsson M, et al. Risk factors for acute cellulitis of the lower limb: a prospective case-control study. Clin Inf Dis. 2005 Nov 15;41(10):1416-22.
Simonsen SE, Van Orman ER, Hatch BE, Jones SS, Gren LH, Hegmann KT, et al. Cellulitis incidence in a defined population. Epidemiol Inf. 2006 Apr;134(2):293-9.
Linder KA, Malani PN. Cellulitis. JAMA. 2017;317(20):2142.
Mzabi A, Marrakchi W, Alaya Z, Fredj FB, Rezgui A, Bouajina E, et al. Cellulitis in aged persons: a neglected infection in the literature. Pan African Med J. 2017;27(1).
Tianyi FL, Mbanga CM, Danwang C, Agbor VN. Risk factors and complications of lower limb cellulitis in Africa: a systematic review. BMJ Open. 2018 Jul 1;8(7):e021175.
Njim T, Aminde LN, Agbor VN, Toukam LD, Kashaf SS, Ohuma EO. Risk factors of lower limb cellulitis in a level-two healthcare facility in Cameroon: a case-control study. BMC Inf Dis. 2017 Dec;17(1):418.
Peterson RA, Polgreen LA, Cavanaugh JE, Polgreen PM. Increasing incidence, cost, and seasonality in patients hospitalized for cellulitis. Open Forum Inf Dis. 2017 Jan 1(4).
Bruun T, Oppegaard O, Kittang BR, Mylvaganam H, Langeland N, Skrede S. Etiology of cellulitis and clinical prediction of streptococcal disease: a prospective study. Open Forum Inf Dis. 2015 Nov,25(3).
Klotz C, Courjon J, Michelangeli C, Demonchy E, Ruimy R, Roger PM. Adherence to antibiotic guidelines for erysipelas or cellulitis is associated with a favorable outcome. European Journal of Clin Microbiol Inf Dis. 2019 Apr 4;38(4):703-9.
Mzabi A, Marrakchi W, Alaya Z, Fredj FB, Rezgui A, Bouajina E, et al. Cellulitis in aged persons: a neglected infection in the literature. Pan African Med J. 2017;27(1).
Ebob-Anya BA, Bassah N, Palle JN. Management of cellulitis and the role of the nurse: a 5-year retrospective multicentre study in Fako, Cameroon. BMC Res Notes. 2019 Dec 1;12(1):452.
Downloads
Published
How to Cite
Issue
Section
